However, a subset of users report mood changes such as sadness, anxiety, or emotional flatness
Patients encountering online sources or private clinics offering this combination should exercise significant caution, as: Unregulated supply of investigational peptides carries serious safety risks Quality, purity, and dosing of unlicensed products cannot be guaranteed Use outside of a clinical trial setting is not supported by current evidence or regulatory frameworks For those seeking access to obesity treatments within a safe and monitored environment, NICE-approved pathways for existing licensed therapies remain the appropriate starting point
In fact, members in the top 25% of Noom app usage were: 100% more likely to renew following their trial month 44% more likely to renew again after that
The GLP-1 hormone slows down the stomach's digestion process, reducing binge eating tendencies, and increasing feelings of fullness
Nausea is typically worst in the first few days following a dose increase